# OnCo record nct01594723 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01594723/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01594723", "NCT01594723" ;
  schema:name "A Study of LY2784544 in Participants With Myeloproliferative Neoplasms"@en ;
  schema:description "A phase 2 trial of 120 mg LY2784544 in myeloproliferative neoplasms, run by Eli Lilly and Company, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct01594723/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01594723> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2012-05-22" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> .